1. Gilead may be looking to buy oncology startup Forty-Seven —FDA announces that COVID-19 has caused its first US drug shortage — Passage Bio raises upsized $216M IPO — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

PruGen $35 copay

Discussion in 'Dermatology' started by anonymous, Oct 21, 2019 at 10:02 PM.

Tags: Edit
  1. anonymous

    anonymous Guest

    Anyone getting feedback from offices about the new $35 copay?

    And why is Pinto out?
     

  2. anonymous

    anonymous Guest

    The moment Angina persists it's an instant trip to the cath lab. Have we gotten our quarter goals smuggled to us secretly before the end of a quarter?
     
  3. anonymous

    anonymous Guest

    Anyone getting feedback from offices about the new $40 copay?

    And why is Squinto out?